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Background: To evaluate the effect of admission hyperglycemia and/or diabetes mellitus (DM) on the outcomes of primary percutaneous coronary 
intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).
Methods: 2482 consecutive patients with STEMI (mean age 56.5 ± 11.9, years, 2064 male) undergoing primary PCI between October 2003 
and March 2008 were retrospectively enrolled into the present study. Hyperglycemia was defined as a venous plasma glucose level ≥200 mg/dl 
on admission. Patients were classified into four groups: non-diabetics/non-hyperglycemic (NDNH, n=1806); diabetics/non-hyperglycemic (DNH, 
n=271); non-diabetics/hyperglycemic (NDH, n=64); and diabetics/hyperglycemic (DH, n=341).
Results: In-hospital mortality was higher in NDH (12.5%) compared to DH (8.5%), DNH (6.3%), and NDNH (0.9%) patients (p<0.001). Composite 
of death, reinfarction, and target-vessel revascularization (major adverse cardiac events [MACE]) in the hospital were also higher in NDH (18.8%) 
compared with other patients (DH, 13.8% vs. DNH, 10.3% vs. NDNH, 3.7%, p<0.001). The median follow-up time was 21 months. The Kaplan-Meier 
survival plot for long-term cardiovascular death was worst for DH patients (Log Rank p<0.001). After adjustment for potentially confounding factors, 
NDH (OR 3.04, 95% CI 1.06-8.73; p=0.03), and DH (OR 2.3, 95% CI 1.29-4.09; p=0.005), but not DNH (OR 1.22, 95% CI 0.57-2.6; p=0.6) status, 
remained independent predictors of long-term cardiovascular mortality.
Conclusions: STEMI patients with NDH represent the highest risk population for in-hospital mortality, and MACE. But worst outcomes for long-term 
cardiovascular mortality occurs in DH patients.
